Press

NICA is pleased to share an important clarification from the Louisiana State Board of Nursing regarding the definition of “compounding” for infusion providers. In their 2023 Examiner, the Board stated that “RNs and APRNs in Louisiana are prohibited from compounding or otherwise mixing drugs, including IV substances and solutions, in non-emergent/non-life-threatening circumstances.” This language caused some confusion among providers accustomed to having infusion nurses prepare medications in accordance with manufacturers’ FDA-approved labeling.

“Around the Nation”

This article synopsis describes how the 5th U.S. Circuit Court of Appeals ruled on September 20, 2024, that the Pharmaceutical Research and Manufacturers of America, the National Infusion Center Association (NICA), and the Global Colon Cancer Association can challenge Medicare’s drug price negotiation program. Previously, a lower court judge in Texas dismissed NICA from the case because it did not have subject matter jurisdiction for the lawsuit. The lower court judge also tossed out the case entirely since NICA was the only party that resided in Texas. Under the federal court’s ruling, the lawsuit will return to the U.S. District Court for the Western District of Texas. (Requires Subscription)

The National Infusion Center Association (NICA) Standards and Accreditation Program has earned the Infusion Nurses Society (INS) Seal of Approval. This prestigious endorsement serves as a hallmark of excellence, affirming that the NICA Accreditation Program has surpassed the stringent criteria of the INS Seal of Approval Program.

“ERT home infusions: Everything you need to know”

This article describes how ERT, or Enzyme replacement therapy, is currently the only available type of approved Pompe disease treatment that addresses the condition’s underlying cause. The NICA Infusion Locator tool is cited as a database of infusion centers in the U.S. and as a patient tool for finding infusion centers based on the specific medications the centers can administer.

The NICA Accreditation Program and the National Infusion Center Association are proud to announce that FloMed Infusion has earned the National Infusion Center Association (NICA) Accreditation of Excellence for Ambulatory Infusion Centers. NICA has completed a rigorous, multifaceted assessment of FloMed Infusion and determined that it has demonstrated the level of excellence required to achieve NICA Accreditation. 

The NICA Accreditation Program and the National Infusion Center Association are proud to announce that Intrafusion by McKesson, Neurological Sciences of Orlando (NSO) has earned the National Infusion Center Association (NICA) Accreditation of Excellence for Ambulatory Infusion Centers. NICA has completed a rigorous, multifaceted assessment of Intrafusion by McKesson and determined that it has demonstrated the level of excellence required to achieve NICA Accreditation. 

The NICA Accreditation Program and the National Infusion Center Association are proud to announce that Ivira Infusions has earned the National Infusion Center Association (NICA) Accreditation of Excellence for Ambulatory Infusion Centers. NICA has completed a rigorous, multifaceted assessment of Ivira Infusions and determined that it has demonstrated the level of excellence required to achieve NICA Accreditation. 

The National Infusion Center Association (NICA), the Global Colon Cancer Association (GCCA), and the Pharmaceutical Research and Manufacturers of America (PhRMA) filed a complaint in U.S. District Court for the Western District of Texas asserting the price-setting provisions in the Inflation Reduction Act are unconstitutional.

The National Infusion Center Association (NICA) announces its collaboration with COSACO, a community health organization based in Puerto Rico, to improve access to COVID-19 monoclonal antibody therapies (CmAbs) for Puerto Ricans and Latinx Americans. COSACO is the Puerto Rico Community Health Coalition.